Title:
COMPOSITION FOR TREATING DIABETIC RETINOPATHY, COMPRISING RAAV CONTAINING SOLUBLE VEGFR-1 VARIANT CDNA
Document Type and Number:
WIPO Patent Application WO/2021/112597
Kind Code:
A1
Abstract:
The present invention relates to a pharmaceutical composition for treating diabetic retinopathy. According to the present invention, the pharmaceutical composition can treat diabetic retinopathy by means of a single administration and thus, compared to conventional treatment methods, which require intraocular injection on a monthly basis, can reduce pain and ocular damage and infections in patients and reduce treatment costs.
Inventors:
LEE HYUN SEUNG (KR)
PARK KEE RANG (KR)
LEE YOUNG-ILL (KR)
PARK KEE RANG (KR)
LEE YOUNG-ILL (KR)
Application Number:
PCT/KR2020/017570
Publication Date:
June 10, 2021
Filing Date:
December 03, 2020
Export Citation:
Assignee:
CDMOGEN CO LTD (KR)
International Classes:
A61K38/17; A61P7/10; A61P27/02
Foreign References:
| KR20150126923A | 2015-11-13 | |||
| KR20190046628A | 2019-05-07 | |||
| KR20180109278A | 2018-10-08 | |||
| US10004788B2 | 2018-06-26 |
Other References:
DATABASE NUCLEOTIDE 7 February 2009 (2009-02-07), ANONYMOUS: "Homo sapiens psVEGFR1p mRNA, complete cds", XP055620306, retrieved from NCBI Database accession no. EU360600
Attorney, Agent or Firm:
LEE, Cheo Young et al. (KR)
Download PDF: